Trihexyphenidyl Hydrochloride

盐酸苯海索

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrihexyphenidyl Hydrochloride
Drug Alias NameTrihexyphenidylumTrihexifenidiloBenzhexol hydrochlorideArtaneParkinane
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsGenetic Predisposition to DiseaseDystonia +[5] 
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaParkinson Disease
Original Approved Country/TerritoryN/A
Original Approved Date1949/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Kansas Medical CenterTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of Southern CaliforniaB. Lederle Gmbh
Active IndicationsDrug-Related Side Effects and Adverse ReactionsGenetic Predisposition to DiseaseDystonia +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN04AA01
Related LinksWikipediaDrugBankKEGG